276 related articles for article (PubMed ID: 23806268)
1. Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett's esophagus.
Izakovicova Holla L; Borilova Linhartova P; Hrdlickova B; Marek F; Dolina J; Rihak V; Kala Z
Hum Immunol; 2013 Sep; 74(9):1161-9. PubMed ID: 23806268
[TBL] [Abstract][Full Text] [Related]
2. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
[TBL] [Abstract][Full Text] [Related]
3. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
[TBL] [Abstract][Full Text] [Related]
4. Prediction of malignant potential in reflux disease: are cytokine polymorphisms important?
Gough MD; Ackroyd R; Majeed AW; Bird NC
Am J Gastroenterol; 2005 May; 100(5):1012-8. PubMed ID: 15842572
[TBL] [Abstract][Full Text] [Related]
5. Relationship of interleukin-1β levels and gastroesophageal reflux disease in Korea.
Kim JJ; Kim N; Hwang S; Kim JY; Kim JY; Choi YJ; Lee DH; Jung HC
J Gastroenterol Hepatol; 2013 Jan; 28(1):90-8. PubMed ID: 23020284
[TBL] [Abstract][Full Text] [Related]
6. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
[TBL] [Abstract][Full Text] [Related]
8. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
9. Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups.
Dickman R; Bautista JM; Wong WM; Bhatt R; Beeler JN; Malagon I; Risner-Adler S; Lam KF; Fass R
Am J Gastroenterol; 2006 Nov; 101(11):2463-9. PubMed ID: 17090277
[TBL] [Abstract][Full Text] [Related]
10. IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population.
Vishnoi M; Pandey SN; Choudhuri G; Mittal B
Cancer Genet Cytogenet; 2008 Oct; 186(2):63-8. PubMed ID: 18940468
[TBL] [Abstract][Full Text] [Related]
11. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
12. Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.
Dura P; van Veen EM; Salomon J; te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
Int J Cancer; 2013 Oct; 133(7):1751-5. PubMed ID: 23504527
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population.
Peng S; Cui Y; Xiao YL; Xiong LS; Hu PJ; Li CJ; Chen MH
Endoscopy; 2009 Dec; 41(12):1011-7. PubMed ID: 19967617
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic values of GerdQ, 24-h ambulatory oesophageal pH and impedance-pH monitoring in Barrett's esophagus, reflux esophagitis and non-erosive reflux disease].
Wang K; Duan LP; Ge Y; Xu ZJ; Xia ZW
Zhonghua Yi Xue Za Zhi; 2011 May; 91(18):1228-32. PubMed ID: 21756791
[TBL] [Abstract][Full Text] [Related]
15. The association of interleukin-4 haplotypes with chronic periodontitis in a Czech population.
Holla LI; Fassmann A; Augustin P; Halabala T; Znojil V; Vanek J
J Periodontol; 2008 Oct; 79(10):1927-33. PubMed ID: 18834248
[TBL] [Abstract][Full Text] [Related]
16. Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis?
Coenraad M; Masclee AA; Straathof JW; Ganesh S; Griffioen G; Lamers CB
Am J Gastroenterol; 1998 Jul; 93(7):1068-72. PubMed ID: 9672332
[TBL] [Abstract][Full Text] [Related]
17. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.
Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
19. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E
Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384
[TBL] [Abstract][Full Text] [Related]
20. Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma.
Menke V; Van Zoest KP; Moons LM; Pot RG; Siersema PD; Kuipers EJ; Kusters JG
Scand J Gastroenterol; 2012 Dec; 47(12):1422-8. PubMed ID: 22954106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]